Reid G, Kim SO, Köhler GA. 2006. Selecting, testing and understanding probiotic microorganisms. FEMS Immunol Med Microbiol 46:149–157.[PubMed][CrossRef]
Rhoads A, Au KF. 2015. PacBio sequencing and its applications. Genomics Proteomics Bioinformatics 13:278–289.[PubMed][CrossRef]
Salyers AA, Gupta A, Wang Y. 2004. Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol 12:412–416.[PubMed][CrossRef]
Samuel BS, Gordon JI. 2006. A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc Natl Acad Sci USA 103:10011–10016.[PubMed][CrossRef]
Stumpf RM, Wilson BA, Rivera A, Yildirim S, Yeoman CJ, Polk JD, White BA, Leigh SR. 2013. The primate vaginal microbiome: comparative context and implications for human health and disease. Am J Phys Anthropol 152(Suppl 57):119–134.[PubMed][CrossRef]
Ursell LK, Metcalf JL, Parfrey LW, Knight R. 2012. Defining the human microbiome. Nutr Rev 70(Suppl 1):S38–S44.[PubMed][CrossRef]
Wischmeyer PE, McDonald D, Knight R. 2016. Role of the microbiome, probiotics, and ‘dysbiosis therapy’ in critical illness. Curr Opin Crit Care 22:347–353.[PubMed][CrossRef]
Yarza P, Yilmaz P, Pruesse E, Glöckner FO, Ludwig W, Schleifer K-H, Whitman WB, Euzéby J, Amann R, Rosselló-Móra R. 2014. Uniting the classification of cultured and uncultured bacteria and archaea using 16S rRNA gene sequences. Nat Rev Microbiol 12:635–645.[PubMed][CrossRef]
Yeoman CJ, Thomas SM, Miller ME, Ulanov AV, Torralba M, Lucas S, Gillis M, Cregger M, Gomez A, Ho M, Leigh SR, Stumpf R, Creedon DJ, Smith MA, Weisbaum JS, Nelson KE, Wilson BA, White BA. 2013. A multi-omic systems-based approach reveals metabolic markers of bacterial vaginosis and insight into the disease. PLoS One 8:e56111.[PubMed][CrossRef]
Yildirim S, Yeoman CJ, Janga SC, Thomas SM, Ho M, Leigh SR, White BA, Wilson BA, Stumpf RM, Primate Microbiome Consortium. 2014. Primate vaginal microbiomes exhibit species specificity without universal Lactobacillus dominance. ISME J 8:2431–2444.[PubMed][CrossRef]
Questions
1. How does a DNA-based analysis, such as the 16S rRNA gene analysis, differ from a cultivation-based analysis? In this chapter, the DNA-based approaches have been emphasized. What are some advantages of the cultivation-based approach?
2. More and more research groups are seeking to show that changes in the microbiota of a particular site are involved in diseases such as periodontal disease, inflammatory bowel disease, and premature birth. Critics object that showing an association is not the same as demonstrating cause and effect. In the case of the obesity study, scientists tried to do this by inoculating germfree mice with different variations of the microbiota. Clearly, this would not be possible in humans. How might you prove cause and effect in humans?
3. Infants in the first years of life are often more susceptible to certain bacterial infections than older children. How can you explain this? What function of the microbiota does this illustrate?
4. Members of the microbiota cause some quite serious diseases. How could a bacterium that normally lives in a beneficial or neutral association with its human host cause serious disease?
5. Metabolic interactions between members of the microbiota are attracting more attention because two microbes working together can increase the effectiveness of a reaction catalyzed by one of them. Consider an association between a polysaccharide-fermenting microbe and a methanogen in the colon. Consider also that the overall energy of a reaction depends on the ratio of substrate to end products for a bacterium like a polysaccharide fermenter. Can you explain why a polysaccharide fermenter and a methanogen might team up in the colon?
6. The assertion is made in this chapter that scientists now believe that transfer of DNA by conjugation in the colon is occurring across species and genus lines. Suppose you found the same type of antibiotic-resistance gene in members of two different genera. What criteria might you use to show that the gene was transferred horizontally? How might you suspect that the gene was transferred by conjugation?
7. Conventional wisdom asserts that there are no methanogens in the vaginal tract. If they were present they would probably be present at low levels. How would you use the 16S rRNA approach to find them? What modification of the approach used to find bacterial sequences would you have to make?
8. PCR combined with sequencing can provide a quick identification of bacteria. What are the limitations of this approach?
9. Resident microbiotas provide protection from colonization of some pathogenic bacteria in certain parts of the body. Describe regions of the body where normal microbiotas are protective and how they accomplish this protection.
For each of the following, choose the most correct answer:
10. The “normal” microbiota of humans is
a. constantly changing.
b. commensal.
c. the same in every individual.
d. parasitic.
11. Removing most of the microorganisms from the intestinal tract would
a. inhibit infections.
b. have no effect on health.
c. lead to diarrhea and maybe other diseases.
d. improve digestion.
12. Which of the following statements about normal microbiotas is not true?
a. Our bodies begin to acquire a normal microbiota within a week of birth.
b. Microbial communities, once established, remain constant throughout one’s lifetime.
c. At the cellular level, our bodies are approximately 50% bacteria.
d. Normal microbiotas can cause disease in humans.
13. Clostridium difficile is an example of
a. how antibiotic use can cause a disease by disturbing the gut microbiota.